Bioceres Crop Solutions Subsidiary Rizobacter Completes $20 Million Offering of Series VII Corporate Bonds

Rhea-AI Summary

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) announced the successful completion of a $20 million public offering of Series VII corporate bonds by its subsidiary Rizobacter Argentina S.A. The bonds, maturing in December 2024, offer an annual interest rate of 1.49%. Proceeds will be allocated to working capital, building HB4 inventories, and for general corporate purposes, aiming to extend debt maturities and lower financing costs.

Positive

• Successful completion of $20 million public bond offering.
• Bonds offer a low annual interest rate of 1.49%.
• Proceeds aimed at enhancing working capital and reducing financing costs.

Negative

• None.

ROSARIO, Argentina--(BUSINESS WIRE)-- Bioceres Crop Solutions Corp. (“Bioceres” or the “Company”) (NASDAQ: BIOX), a fully-integrated global provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, announced today that its subsidiary Rizobacter Argentina S.A. (“Rizobacter”) has completed a $20 million public offering of Series VII corporate bonds in the Argentine market. The bonds mature in December 2024 and pay an annual nominal interest rate of 1.49%.

Proceeds will be used to support working capital and build HB4 inventories, as well as for general corporate purposes, while extending debt maturities and reducing financing costs.

About Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) is a fully integrated provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality. To do this, Bioceres’ solutions create economic incentives for farmers and other stakeholders to adopt environmentally friendlier production practices. The Company has a unique biotech platform with high-impact, patented technologies for seeds and microbial ag-inputs, as well as next generation crop nutrition and protection solutions. Through its HB4® program, the Company is bringing digital solutions to support growers’ decisions and provide end-to-end traceability for production outputs. For more information, visit here.

Forward-looking statements

This communication includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “believe,” “expect,” “estimate,” “plan,” “outlook,” and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements are based on management’s reasonable current assumptions, expectations, plans and forecasts regarding the Company’s current or future results and future business and economic conditions more generally. Such forward-looking statements involve risks, uncertainties and other factors, which may cause the actual results, levels of activity, performance or achievement of the Company to be materially different from any future results expressed or implied by such forward-looking statements, and there can be no assurance that actual results will not differ materially from management’s expectations or could affect the Company’s ability to achieve its strategic goals, including the uncertainties relating to the impact of COVID-19 on the Company’s business, operations, liquidity and financial results and the other factors that are described in the sections entitled “Risk Factors” in the Company's Securities and Exchange Commission filings updated from time to time. The preceding list is not intended to be an exhaustive list of all of our forward-looking statements. Therefore, you should not rely on any of these forward-looking statements as predictions of future events. All forward-looking statements contained in this release are qualified in their entirety by this cautionary statement. Forward-looking statements speak only as of the date they are or were made, and the Company does not intend to update or otherwise revise the forward-looking statements to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211223005109/en/

Investor Relations Contact

Chris Tyson

Executive Vice President

MZ Group – MZ North America

(949) 491-8235

BIOX@mzgroup.us

www.mzgroup.us

Bioceres Crop Solutions

Rodrigo Krause

Head of Investor Relations

investorrelations@biocerescrops.com

Source: Bioceres Crop Solutions Corp.

FAQ

What was announced by Bioceres Crop Solutions on December 23, 2021?

Bioceres announced a $20 million public offering of Series VII corporate bonds by its subsidiary Rizobacter.

What is the maturity date of the new bonds issued by Bioceres?

The bonds mature in December 2024.

What is the annual interest rate for the bonds issued by Rizobacter?

The bonds offer an annual nominal interest rate of 1.49%.

How will Bioceres utilize the proceeds from the bond offering?

The proceeds will be used for working capital, building HB4 inventories, and general corporate purposes.

What is the stock symbol for Bioceres Crop Solutions?

The stock symbol for Bioceres Crop Solutions is BIOX.